Skip to main content

Table 1 Characteristics of the study population (n = 2208)

From: Impact of rehabilitation on mortality and readmissions after surgery for hip fracture

 

Hospital rehabilitation (N = 519)

IRF rehabilitation (N = 907)

No rehabilitation (N = 782)

p-value

Significant post-hoc comparisons

Age, mean (SD)

83.8 (7.3)

83.7 (7.1)

84.5 (7.8)

0.055*

 

N. comorbidities, mean (SD)

3.4 (2.0)

2.1 (2.1)

2.2 (2.0)

< 0.001*

hosp>IRF, no rehab

Length of stay, days (SD)

35.2 (18.2)

34.2 (13.6)

11.5 (7.2)

< 0.001*

hosp, IRF > no rehab

Sex, male, n (%)

134 (25.8)

211 (23.3)

186 (23.8)

0.542

 

Myocardial infarction, n (%)

46 (7.1)

119 (5.1)

36 (4.6)

0.122

 

Heart failure, n (%)

151 (29.1)

160 (17.6)

132 (16.9)

< 0.001

hosp>IRF, no rehab

Peripheral vascular dis., n (%)

185 (36.6)

216 (23.8)

148 (18.9)

< 0.001

hosp>IRF > no rehab

Cerebrovascular dis., n (%)

102 (19.7)

79 (8.7)

127 (16.2)

< 0.001

hosp, no rehab>IRF

Dementia, n (%)

112 (21.6)

113 (12.5)

170 (21.7)

< 0.001

hosp, no rehab>IRF

Hypertension, n (%)

28 (5.4)

74 (8.2)

50 (6.4)

0.111

 

Neurological disease, n (%)

219 (42.2)

51 (5.6)

76 (9.7)

< 0.001

hosp>no rehab>IRF

Renal disease, n (%)

76 (14.6)

72 (7.9)

69 (8.8)

< 0.001

hosp>IRF, no rehab

Domiciliary care, n (%)

151 (29.1)

226 (24.9)

253 (32.3)

0.003

no rehab>IRF

Intervention > 2 days, n (%)

133 (25.6)

226 (24.9)

155 (19.8)

0.017

hosp, IRF > no rehab

Hip fracture reduction, n (%)

272 (52.4)

482 (52.1)

461 (58.9)

0.022

 

Polytrauma, n (%)

34 (6.6)

59 (6.5)

53 (6.8)

0.973

 

Open fracture, n (%)

6 (1.2)

70 (7.7)

45 (5.8)

< 0.001

No rehab, IRF > hosp

Died, n (%)

60 (11.6)

140 (15.4)

163 (20.8)

< 0.001

No rehab>hosp, IRF

Hospital readmission within 6 months, all causes, n(%)a

165 (32.8)

211 (24.3)

185 (25.1)

0.001

hosp>IRF, no rehab

Hospital readmission within 6 months, orthopedic, n(%)a

16 (3.2)

24 (2.8)

30 (4.1)

0.337

 
  1. Note: χ2 test was used, except where indicated. *Kruskal-Wallis test
  2. aIn the 2107 patients alive at the end of the episode of care